LY2624803 + activated charcoal

LY2624803 + activated charcoal is an experimental combination where the investigational insomnia treatment **LY2624803** (a small molecule antagonist of histamine and serotonin receptors) is co-administered or studied in the presence of **activated charcoal**, which is a nonspecific adsorbent used in overdose and poisoning to decrease gastrointestinal drug absorption. LY2624803 is designed to induce sleep by targeted receptor antagonism without broad CNS depression, while activated charcoal acts by adsorbing substances in the GI tract, reducing primary absorption and interfering with enterohepatic recirculation of some drugs. The combination is specifically used in clinical pharmacology to study and modulate the absorption kinetics and bioavailability of LY2624803 by leveraging the adsorptive properties of activated charcoal[2][5]. Activated charcoal is not an active therapy for insomnia; its use here is strictly as a pharmacokinetic tool or in case management of overdose or interaction studies.

Brand names

ActidoseInsta-char

Other names

activated carboncarbo activatusmedicinal charcoal